GENOVATE BIOTECHNOLOGY CO. LTD. financial statements, including revenue, expenses, profit, and loss

The total revenue of 4130 for the last quarter is 126.38 M TWD, and it's 0.41% lower compared to the previous quarter. The net income of Q3 24 is 5.56 M TWD.